Connection
Prem Subramanian to Methylprednisolone
This is a "connection" page, showing publications Prem Subramanian has written about Methylprednisolone.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.048 |
|
|
|
-
Douglas RS, Dailey R, Subramanian PS, Barbesino G, Ugradar S, Batten R, Qadeer RA, Cameron C. Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison. JAMA Ophthalmol. 2022 04 01; 140(4):328-335.
Score: 0.048